Myelofibrosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{Myelofibrosis}}
{{Myelofibrosis}}
{{CMG}}
{{CMG}}{{AE}}{{SR}}


==Overview==
==Overview==


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
The prevalence of myelofibrosis is approximately 1 per 100,000 individuals worldwide.<ref name=epidemiologyofmyelofibrosis1radio1>Epidemiology of myelofibrosis. Dr Henry Knipe and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 8, 2016</ref>
===Age===
===Age===
The disorder usually develops slowly, in people over 50 years old.
Myelofibrosis is a disease that tends to affect the middle-aged and elderly population.<ref name=epidemiologyofmyelofibrosis1radio1>Epidemiology of myelofibrosis. Dr Henry Knipe and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 8, 2016</ref>


==References==
==References==
Line 16: Line 17:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Needs content]]
[[Category:Oncology]]
[[Category:Hematology]]
[[Category:Hematology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 14:50, 8 March 2016

Myelofibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelofibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelofibrosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelofibrosis epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelofibrosis epidemiology and demographics

CDC on Myelofibrosis epidemiology and demographics

Myelofibrosis epidemiology and demographics in the news

Blogs on Myelofibrosis epidemiology and demographics

Directions to Hospitals Treating Myelofibrosis

Risk calculators and risk factors for Myelofibrosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

The prevalence of myelofibrosis is approximately 1 per 100,000 individuals worldwide.[1]

Age

Myelofibrosis is a disease that tends to affect the middle-aged and elderly population.[1]

References

  1. 1.0 1.1 Epidemiology of myelofibrosis. Dr Henry Knipe and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 8, 2016


Template:WikiDoc Sources